<%= message.delivery.preHeader %>
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  
View online
Important Safety Information   |   Prescribing Information
FREHEMGO® (denecimig-mima) injection is a prescription medicine that is used to prevent or reduce the number of bleeding episodes in adults and children with hemophilia A with or without Factor 8 inhibitors.
Welcome to your FREHEMGO® Insider Era
Thanks for signing up to be a FREHEMGO® Insider! Now you can take the next step and connect with your local Novo Nordisk Rare Blood Community Liaison (RBCL). RBCLs exist to support the hemophilia community—and they’re here for you every step of the way. They can…
 
Break down how FREHEMGO® works
Give you a live pen demonstration
Explain the ins and outs of NovoCare® patient support services
Get you up to speed with product information
Talk through your treatment goals, questions, and concerns
RBCLs are here for all of it. So when you’re ready to go for it…
Connect with your RBCL
Important Safety Information for FREHEMGO®
What is the most important information I should know about FREHEMGO®?
  • Lorem ipsum dolor sit amet, consectetur adipiscing elit.
  • Ut rutrum sollicitudin vulputate. Nunc tincidunt blandit tempor. Maecenas at tincidunt diam. Etiam urna erat, ullamcorper egestas nunc accumsan
Please click here or scroll below for additional Important Safety Information.
Look out for live event updates, deeper dives on how FREHEMGO® works, support services info, and more! Being a FREHEMGO® Insider means you’re the first to know about what’s new and what’s next from Novo Nordisk. Thanks for signing up—we’ll talk to ya soon…
Zach lives with hemophilia A.
Talk to your doctor before trying a new activity.
 
 
Enter your FREHEMGO® era
FREHEMGO® shows up with up to a full month of proven bleed protection for adults, adolescents, and children living with hemophilia A with or without inhibitors.a
Wondering why you should go for it?
See for yourself!
Want to see how it works?
Start here!
Looking for patient support services?
Get the info now!
aAlso available as once-every-2-week and once-weekly dosing.
What is FREHEMGO®
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
  • Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Pretium viverra suspendisse potenti nullam. Vestibulum lectus mauris ultrices eros in cursus turpis. Parturient montes nascetur ridiculus mus mauris. Pharetra convallis posuere morbi leo. A lacus vestibulum sed arcu non. Sodales neque sodales ut etiam. Nam aliquam sem et tortor. Felis bibendum ut tristique et egestas quis. Nunc sed blandit libero volutpat sed cras ornare arcu.
  • Ut rutrum sollicitudin vulputate. Nunc tincidunt blandit tempor. Maecenas at tincidunt diam. Etiam urna erat, ullamcorper egestas nunc accumsan
Important Safety Information (cont’d)
What is the most important information I should know about FREHEMGO®? (cont'd)
  • Lorem ipsum dolor sit amet, consectetur adipiscing elit.
  • Ut rutrum sollicitudin vulputate. Nunc tincidunt blandit tempor. Maecenas at tincidunt diam. Etiam urna erat, ullamcorper egestas nunc accumsan
Praesent tincidunt sapien ac venenatis lobortis?
  • Lorem ipsum dolor sit amet, consectetur adipiscing elit.
  • Ut rutrum sollicitudin vulputate. Nunc tincidunt blandit tempor. Maecenas at tincidunt diam. Etiam urna erat, ullamcorper egestas nunc accumsan
  • Praesent tincidunt sapien ac venenatis lobortis. Cras consequat tincidunt ligula sed molestie. In hac habitasse platea dictumst.
Pellentesque elementum sapien et dui malesuada?
  • Lorem ipsum dolor sit amet, consectetur adipiscing elit.
  • Ut rutrum sollicitudin vulputate. Nunc tincidunt blandit tempor. Maecenas at tincidunt diam. Etiam urna erat, ullamcorper egestas nunc accumsan
Please click here for Prescribing Information.
FREHEMGO® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please do not respond to this email. If you would like to contact us, please click here or call 1‑877‑744‑2579.
UNSUBSCRIBE NOTICE
If you no longer want to receive communications from Novo Nordisk, click here to unsubscribe. You also may call us at 1-877-744-2579 or send us a letter that includes your full contact information (eg, name, email address, phone) to Novo Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey 08536. To better understand how Novo Nordisk values your privacy, see our Privacy Statement.
FREHEMGO® and NovoCare® are registered trademarks of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2026 Novo Nordisk  All rights reserved.  US26DENE00104  September 2026
Novo Nordisk logo.
Novo Nordisk logo.